Monika Kumaraswamy

Title(s)Associate Clinical Professor, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San Diego, San Diego, CA06/2015Infectious Diseases Fellowship
    Case Western Reserve University, Cleveland, OH06/2012Internal Medicine Residency
    Medical College of Wisconsin, Milwaukee, WIMD05/2009Medicine
    Northern Arizona University, Flagstaff, AZBS05/2004Microbiology
    Northern Arizona University, Flagstaff, AZBS05/2004Chemistry

    Collapse Overview 
    Collapse Overview
    Dr. Monika Kumaraswamy, MD, D(ABMM) is an Associate Professor of Medicine in the Division of Infectious Diseases and Global Public Health at UC San Diego, Associate Director of the Clinical Microbiology Laboratory at the VA San Diego Healthcare, and a physician scientist with subspecialty expertise in infectious diseases. Dr. Kumaraswamy's primary research interests include modernizing antimicrobial susceptibility testing, developing new diagnostic testing modalities, and identifying novel therapeutic strategies to combat multi-drug resistant bacterial infections by understanding the interactions of innate host defense with conventional antibiotics and mechanisms of antibiotic resistance.

    Collapse Research 
    Collapse Research Activities and Funding
    Surprising Efficacy of Discounted Antibiotics vs. MDR Gram-Negative Pathogens Occurring Through Innate Immune Sensitization
    NIH R01AI145310Aug 1, 2020 - Jul 31, 2024
    Role: Co-Principal Investigator
    Monoclonal Ab Therapy vs. Pseudomonas aeruginosa
    Inhibrix, Inc. Jul 1, 2018 - Jan 31, 2019
    Role: Principal Investigator
    Clostridium difficile CLOVER Trial
    Pfizer Jul 1, 2017 - Jun 30, 2020
    Role: Co-Investrigator
    Mentored Career Development Program
    NIH KL2TR001444Aug 13, 2015 - Apr 30, 2025
    Role: Principal Investigator (CDA Recipient)

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Contribution of Streptococcus pyogenes M87 protein to innate immune resistance and virulence. Microb Pathog. 2022 Aug; 169:105636. Hirose Y, Kolesinski P, Hiraoka M, Uchiyama S, Zurich RH, Kumaraswamy M, Bjanes E, Ghosh P, Kawabata S, Nizet V. PMID: 35724830.
      View in: PubMed   Mentions:    Fields:    
    2. Bacterial Membrane-Derived Vesicles Attenuate Vancomycin Activity against Methicillin-Resistant Staphylococcus aureus. Microorganisms. 2021 Sep 29; 9(10). Kumaraswamy M, Wiull K, Joshi B, Sakoulas G, Kousha A, Vaaje-Kolstad G, Johannessen M, Hegstad K, Nizet V, Askarian F. PMID: 34683376; PMCID: PMC8539228.
      View in: PubMed   Mentions: 1  
    3. Using diagnostic stewardship to reduce rates, healthcare expenditures and accurately identify cases of hospital-onset Clostridioides difficile infection. Infect Control Hosp Epidemiol. 2021 01; 42(1):51-56. Solanky D, Juang DK, Johns ST, Drobish IC, Mehta SR, Kumaraswamy M. PMID: 32943129; PMCID: PMC9215221.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    4. Duloxetine-Induced Hyponatremia in an Elderly Male Patient with Treatment-Refractory Major Depressive Disorder. Case Rep Psychiatry. 2019; 2019:4109150. Sun CF, Chen YL, Li YH, Kumaraswamy M, Lo YC, Chen YT. PMID: 31214374; PMCID: PMC6535824.
      View in: PubMed   Mentions: 2  
    5. Erratum for Schooley et al., "Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection". Antimicrob Agents Chemother. 2018 12; 62(12). Schooley RT, Biswas B, Gill JJ, Hernandez-Morales A, Lancaster J, Lessor L, Barr JJ, Reed SL, Rohwer F, Benler S, Segall AM, Taplitz R, Smith DM, Kerr K, Kumaraswamy M, Nizet V, Lin L, McCauley MD, Strathdee SA, Benson CA, Pope RK, Leroux BM, Picel AC, Mateczun AJ, Cilwa KE, Regeimbal JM, Estrella LA, Wolfe DM, Henry MS, Quinones J, Salka S, Bishop-Lilly KA, Young R, Hamilton T. PMID: 30478181; PMCID: PMC6256779.
      View in: PubMed   Mentions: 7     Fields:    
    6. Decontaminating surfaces with atomized disinfectants generated by a novel thickness-mode lithium niobate device. Appl Microbiol Biotechnol. 2018 Aug; 102(15):6459-6467. Kumaraswamy M, Collignon S, Do C, Kim J, Nizet V, Friend J. PMID: 29804135; PMCID: PMC6082180.
      View in: PubMed   Mentions: 2     Fields:    Translation:CellsPHPublic Health
    7. Phage Therapy for a Multidrug-Resistant Acinetobacter baumannii Craniectomy Site Infection. Open Forum Infect Dis. 2018 Apr; 5(4):ofy064. LaVergne S, Hamilton T, Biswas B, Kumaraswamy M, Schooley RT, Wooten D. PMID: 29687015; PMCID: PMC5905571.
      View in: PubMed   Mentions: 65  
    8. Staphylococcus aureus Membrane-Derived Vesicles Promote Bacterial Virulence and Confer Protective Immunity in Murine Infection Models. Front Microbiol. 2018; 9:262. Askarian F, Lapek JD, Dongre M, Tsai CM, Kumaraswamy M, Kousha A, Valderrama JA, Ludviksen JA, Cavanagh JP, Uchiyama S, Mollnes TE, Gonzalez DJ, Wai SN, Nizet V, Johannessen M. PMID: 29515544; PMCID: PMC5826277.
      View in: PubMed   Mentions: 23  
    9. Listeria monocytogenes endocarditis: case report, review of the literature, and laboratory evaluation of potential novel antibiotic synergies. Int J Antimicrob Agents. 2018 Mar; 51(3):468-478. Kumaraswamy M, Do C, Sakoulas G, Nonejuie P, Tseng GW, King H, Fierer J, Pogliano J, Nizet V. PMID: 29337066; PMCID: PMC5860678.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    10. Interaction of Antibiotics with Innate Host Defense Factors against Salmonella enterica Serotype Newport. mSphere. 2017 Nov-Dec; 2(6). Sakoulas G, Kumaraswamy M, Kousha A, Nizet V. PMID: 29242830; PMCID: PMC5717323.
      View in: PubMed   Mentions: 16     Fields:    
    11. Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection. Antimicrob Agents Chemother. 2017 10; 61(10). Schooley RT, Biswas B, Gill JJ, Hernandez-Morales A, Lancaster J, Lessor L, Barr JJ, Reed SL, Rohwer F, Benler S, Segall AM, Taplitz R, Smith DM, Kerr K, Kumaraswamy M, Nizet V, Lin L, McCauley MD, Strathdee SA, Benson CA, Pope RK, Leroux BM, Picel AC, Mateczun AJ, Cilwa KE, Regeimbal JM, Estrella LA, Wolfe DM, Henry MS, Quinones J, Salka S, Bishop-Lilly KA, Young R, Hamilton T. PMID: 28807909; PMCID: PMC5610518.
      View in: PubMed   Mentions: 305     Fields:    Translation:HumansCells
    12. Cefazolin and Ertapenem, a Synergistic Combination Used To Clear Persistent Staphylococcus aureus Bacteremia. Antimicrob Agents Chemother. 2016 11; 60(11):6609-6618. Sakoulas G, Olson J, Yim J, Singh NB, Kumaraswamy M, Quach DT, Rybak MJ, Pogliano J, Nizet V. PMID: 27572414; PMCID: PMC5075066.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    13. Standard susceptibility testing overlooks potent azithromycin activity and cationic peptide synergy against MDR Stenotrophomonas maltophilia. J Antimicrob Chemother. 2016 May; 71(5):1264-9. Kumaraswamy M, Lin L, Olson J, Sun CF, Nonejuie P, Corriden R, Döhrmann S, Ali SR, Amaro D, Rohde M, Pogliano J, Sakoulas G, Nizet V. PMID: 26832758; PMCID: PMC4830416.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimalsCells
    14. Differential Effects of Penicillin Binding Protein Deletion on the Susceptibility of Enterococcus faecium to Cationic Peptide Antibiotics. Antimicrob Agents Chemother. 2015 Oct; 59(10):6132-9. Sakoulas G, Kumaraswamy M, Nonejuie P, Werth BJ, Rybak MJ, Pogliano J, Rice LB, Nizet V. PMID: 26195528; PMCID: PMC4576044.
      View in: PubMed   Mentions: 3     Fields:    Translation:Cells
    15. Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens. EBioMedicine. 2015 Jul; 2(7):690-8. Lin L, Nonejuie P, Munguia J, Hollands A, Olson J, Dam Q, Kumaraswamy M, Rivera H, Corriden R, Rohde M, Hensler ME, Burkart MD, Pogliano J, Sakoulas G, Nizet V. PMID: 26288841; PMCID: PMC4534682.
      View in: PubMed   Mentions: 104     Fields:    Translation:HumansAnimalsCells
    Monika's Networks
    Concepts (78)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (21)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version v3.1.0-871-g21b54b14 on PROFILES-PWEB01.

    Copyright © The Regents of the University of California